Researchers find genetic variation that lowers effect of cholesterol drugs

A U.S. study of 1,500 people treated with statins found those who had a common genetic variation affecting how they synthesize cholesterol had a total cholesterol reduction that was 22% smaller than others after six months. The researchers said their findings could result in pharmacogenetic screening that would help doctors prescribe the right dosage of statin medicine for their patients.

View Full Article in:

Reuters · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN